4 unknown, 2 completed, 1 not yet recruiting, 1 withdrawn. 8 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Unknown 4, Completed 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 4 | Unknown 2, Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Vaccine Reaction: new trials by email Literature Review of Vaccine Reaction trials Research Report on Vaccine Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II, Open Label, Randomized, Safety and Immunogenicity Following DTwP-Hepatitis B-Hib-IPV Vaccine (Bio Farma) in Indonesian Infants DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula A, DTwP-Hepatitis B-Hib-IPV (Bio Farma) Vaccine Formula B, Registered DTwP-Hepatitis B-Hib Vaccine and IPV (Sinovac)® - Vaccine Adverse Reaction, Vaccine Reaction | Phase 1 / Phase 2 | Not yet recruiting | PT Bio Farma | 465 | 2025-03-01 | 2024-11-15 |
| Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System Gardasil, PharmaJet Stratis® Needle-Free Injection System, PharmaJet Tropis® Needle-Free Injection System - Vaccine Reaction | Phase 2 | Withdrawn | PharmaJet, Inc. | 2024-05-31 | 2024-05-24 | |
| Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine Ad26.COV2.S - COVID-19, Vaccine Reaction | Phase 2 | Unknown | ANRS, Emerging Infectious Diseases | 200 | 2022-06-02 | 2024-03-27 |
| Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer Coronavirus vaccination - Patients With Cancer, Vaccine Reaction | Phase 1 / Phase 2 | Unknown | Beijing 302 Hospital | 100 | 2022-02-11 | 2022-04-18 |
| UNAIR Inactivated COVID-19 Vaccine UNAIR Inactivated COVID-19 Vaccine, CoronaVac Biofarma COVID-19 Vaccine - COVID-19 Pandemic, Vaccine Reaction | Phase 1 / Phase 2 | Unknown | Dr. Soetomo General Hospital | 495 | 2022-02-08 | 2023-06-15 |
| Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen IMIQUIMOD cream, HEPATITIS B SURFACE ANTIGEN - Cirrhosis, Liver, Vaccination Failure | Phase 2 | Unknown | Central Hospital, Nancy, France | 60 | 2021-11-01 | 2021-08-31 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine Influenza vaccine [inactivated] - Influenza, Influenza, Human | Phase 2 / Phase 3 | Completed | St. Petersburg Research Institute of Vaccines and Sera | 450 | 2020-10-06 | 2023-05-22 |
| A Bridging Study of the SYN023 on Healthy Adult Subjects recombinant anti-rabies human monoclonal antibody injection (SYN023), Rabies Vaccine - Communicable Disease Transmission, Zoonotic Disease | Phase 1 / Phase 2 | Completed | Synermore Biologics (Suzhou) Co., Ltd. | 33 | 2019-02-26 | 2021-09-29 |
COVID-19 (3) · Infections (1) · Influenza, Human (1) · Liver Cirrhosis (1) · Zoonoses (1)
Infections (4) · RNA Virus Infections (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4) · Virus Diseases (4) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · Animal Diseases (1) · Digestive System Diseases (1) · Fibrosis (1) · Liver Diseases (1)
Ad26COVS1 (1) · Hepatitis B Surface Antigens (1) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1) · Influenza Vaccines (1) · Poliovirus Vaccine, Inactivated (1) · Rabies Vaccines (1)
ANRS, Emerging Infectious Diseases (1) · Beijing 302 Hospital (1) · Central Hospital, Nancy, France (1) · Dr. Soetomo General Hospital (1) · PT Bio Farma (1) · PharmaJet, Inc. (1) · St. Petersburg Research Institute of Vaccines and Sera (1) · Synermore Biologics (Suzhou) Co., Ltd. (1)
Indonesia (3) · China (2) · Mali (1) · Russia (1)
Dominicus Husada, MD (1) · Ellina Ruzanova (1) · Odile Launay (1) · Samba Sow (1) · Shu-juan Li, MD (1)
PMID 29261658, PMID 33091433, PMID 42767612
R44CA261326 (1)